﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>15</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>09</Month>
        <DAY>25</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Continuous Uptake of MiR-181a-2 Mimetic Induces Constitutive Overexpression of Cellular MiR-181a-2 in MCF-7 Breast Cancer Cells: Links with Progression of Drug Resistance</ArticleTitle>
    <FirstPage>678</FirstPage>
    <LastPage>685</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.025.43440</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Olga Evgen’evna</FirstName>
        <LastName>Andreeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6015-6619</Identifier>
      </Author>
      <Author>
        <FirstName>Danila Vladimirovich</FirstName>
        <LastName>Sorokin</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1264-7405</Identifier>
      </Author>
      <Author>
        <FirstName>Svetlana Vladimirovna</FirstName>
        <LastName>Vinokurova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1615-3928</Identifier>
      </Author>
      <Author>
        <FirstName>Pavel Borisovich</FirstName>
        <LastName>Kopnin</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2078-4274</Identifier>
      </Author>
      <Author>
        <FirstName>Nadezhda Viacheslavovna</FirstName>
        <LastName>Elkina</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0503-6016</Identifier>
      </Author>
      <Author>
        <FirstName>Danila Sergeevich</FirstName>
        <LastName>Elkin</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4793-6063</Identifier>
      </Author>
      <Author>
        <FirstName>Maria Dmitrievna</FirstName>
        <LastName>Fedorova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8813-7516</Identifier>
      </Author>
      <Author>
        <FirstName>Alexander Mikhailovich</FirstName>
        <LastName>Scherbakov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2974-9555</Identifier>
      </Author>
      <Author>
        <FirstName>Mikhail Aleksandrovich</FirstName>
        <LastName>Krasil’nikov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5902-7633</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.025.43440</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: The aim of this study was to elucidate the mechanisms underlying the formation and maintenance of drug resistance in cancer cells. Previously, we demonstrated that prolonged treatment of estrogen-dependent MCF-7 breast cancer cells with exosomes derived from estrogen-resistant MCF-7/T cells leads to a partial loss of estrogen sensitivity in MCF-7 cells. Moreover, repeated transfection with one of the exosomal microRNAs—microRNA-181a-2—induced an irreversible decrease in hormonal sensitivity in the recipient cells. In the present work, to further investigate the possible mechanism of miR-181a-2-induced acquired resistance, we analyzed the effect of multiple miR-181a-2 transfections on the expression of cellular miR-181a-2 and related signaling proteins. Methods: miR-181a-2 was ectopically expressed by mimetic transfection or suppressed by antisense oligonucleotides. miR-181a-2 precursor/MIR181A2HG expression (qRT-PCR) and MIR181A2 locus copy number (qPCR) were assessed. wtSnail was expressed via transient transfection. Tamoxifen sensitivity was measured by MTT assay. Protein expression was studied by immunoblotting, estrogen receptor α/Snail transcriptional activity was evaluated by reporter analysis. Results: We found that multiple transfections with miR-181a-2 resulted in a marked increase in cellular miR-181a-2 precursor levels, whereas single transfection had no such effect. Similarly, stable transfection with miR-181a-2 led to increased levels of cellular miR-181a-2 and its host gene, MIR181A2HG, which was associated with partial resistance to tamoxifen. Analysis of the genomic DNA encoding miR-181a-2 revealed no changes in copy number in transfected cells. Furthermore, we identified the transcription factor Snail as a key mediator of miR-181a-2–induced resistance and demonstrated its role in the formation of an autoregulatory loop of miR181a-2 and the maintenance of cell resistance. Conclusion: Overall, these results reveal a novel mechanism of resistance-associated signaling pathway rearrangement based on the formation of a miR-181a-2 autoregulatory loop.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MCF-7</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MicroRNA</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MiR-181a-2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Snail</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Tamoxifen resistance</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>